Alaunos Therapeutics has completed the acquisition of Velaris Therapeutics, gaining a pipeline of therapies targeting pulmonary arterial hypertension (PAH) and related diseases. The deal was accompanied by a $350 million private placement to fund operations through 2029, supporting clinical milestones including proof-of-concept data for Velaris' lead drug VLR199 expected in 2028. Velaris develops ActRII-Fc ligand traps and an anti-PDGF-B antibody aimed at correcting signaling imbalances that cause pulmonary vascular remodeling. This acquisition strengthens Alaunos' position in cardiopulmonary disease treatment and offers potential for combination therapies addressing multiple pathways in PAH and secondary pulmonary hypertension.
The acquisition of Velaris Therapeutics by Alaunos Therapeutics provides context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 13, 2026 21:31 WIB: Of 128 priced health-sector US stocks, 17 rose and 110 fell. Notable movers include Johnson & Johnson (JNJ) at USD 251.94 with a 1-day change of -4.47% and a typical hold time of 129 days, Inovio Pharmaceuticals Inc (INO) at USD 1.06 with a -4.07% change and an 82% buy order activity, and Neurocrine Biosciences Inc (NBIX) at USD 136.20 with a -3.66% change and 100% sell order activity on Pluang.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
